Company: RGNT
Filing Date: 2025-03-11
Form Type: F-1
Source: 0001213900-25-022350
Chunk: 229

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-03-11
Form: F-1
Chunk 229
---
 shares of our capital stock; (b) file or caused to be filed any registration statement with the Commission
relating to the offering of any shares of our capital stock or any securities convertible into or exercisable or exchangeable for shares
of our capital stock; (c) complete any offering of our debt securities, other than entering into a line of credit with a traditional
bank or (d) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences
of ownership of our capital stock, whether any such transaction described in clause (a), (b), (c) or (d) above is to be settled by delivery
of shares of our capital stock or such other securities, in cash or otherwise. We agree to file a customary universal shelf registration
statement within 30 days of the earlier of (i) the expiration of the restricted period described above and (ii) the date of its initial
eligibility to do so. Additionally, we agree that for a period of 24 months after the offering we will not directly or indirectly offer
to sell, sell, contract to sell, grant any option to sell or otherwise dispose of shares of our capital stock or any securities convertible
into or exercisable or exchangeable for shares of our capital stock in any “at-the-market”, continuous equity or variable
rate transaction, without the prior written consent of the Representative.

Right of First Refusal

We will grant the Representative
a right of first refusal, for a period of 36 months from the closing of the offering, to act as sole investment banker, sole book-runner
and/or sole placement agent, at the Representative’s sole discretion, for each and every future public and private equity and debt
offering, including all equity linked financings, during such 36-month period, for us, or any successor to or any subsidiary of us, on
terms customary for the Representative. The Representative will have the sole right to determine whether any other broker-dealer shall
have the right to participate in any such offering and the economic terms of any such participation. any other broker-dealer shall have
the right to participate in any such offering and the economic terms of any such participation.

<div align='center'>138</div>

Pricing of the Offering

Prior to this offering, there
was no established public market for our Ordinary Shares. The public offering price will be negotiated between us and the underwriters.
In determining the price, we will consider our history